Role of N-Methyl-D-Aspartate Receptors in Action-Based Predictive Coding Deficits in Schizophrenia

被引:37
|
作者
Kort, Naomi S. [1 ]
Ford, Judith M. [1 ,2 ]
Roach, Brian J. [3 ]
Gunduz-Bruce, Handan [4 ,5 ]
Krystal, John H. [4 ,5 ]
Jaeger, Judith [6 ,7 ,8 ]
Reinhart, Robert M. G. [4 ,9 ]
Mathalon, Daniel H. [1 ,2 ,10 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA USA
[2] San Francisco VA Med Ctr, San Francisco, CA USA
[3] Northern California Inst Res & Educ, San Francisco, CA USA
[4] Yale Univ, Sch Med, New Haven, CT USA
[5] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA
[6] Clin Dev AstraZeneca Pharmaceut, Wilmington, DE USA
[7] Albert Einstein Coll York, Yorktown Hts, NY USA
[8] LLC, CognitionMetr, Wilmington, DC USA
[9] Boston Univ, Boston, MA USA
[10] Mental Hlth Serv 116D, SFVAMC, 4150 Clement St, San Francisco, CA 94121 USA
关键词
Electroencephalography; Ketamine; N-methyl-D-aspartate glutamate receptor; Predictive coding; Schizophrenia; Speech motor control; COROLLARY DISCHARGE DYSFUNCTION; AUDITORY SENSORY MEMORY; MISMATCH NEGATIVITY GENERATION; SUBUNIT GENE GRIN2B; HEALTHY-VOLUNTEERS; SPEECH PRODUCTION; SYNAPTIC PLASTICITY; NEUROPHYSIOLOGICAL EVIDENCE; COGNITIVE DEFICITS; PSYCHOTIC SYMPTOMS;
D O I
10.1016/j.biopsych.2016.06.019
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BACKGROUND: Recent theoretical models of schizophrenia posit that dysfunction of the neural mechanisms subserving predictive coding contributes to symptoms and cognitive deficits, and this dysfunction is further posited to result from N-methyl-D-aspartate glutamate receptor (NMDAR) hypofunction. Previously, by examining auditory cortical responses to self-generated speech sounds, we demonstrated that predictive coding during vocalization is disrupted in schizophrenia. To test the hypothesized contribution of NMDAR hypofunction to this disruption, we examined the effects of the NMDAR antagonist, ketamine, on predictive coding during vocalization in healthy volunteers and compared them with the effects of schizophrenia. METHODS: In two separate studies, the N1 component of the event-related potential elicited by speech sounds during vocalization (talk) and passive playback(listen) were compared to assess the degree of N1 suppression during vocalization, a putative measure of auditory predictive coding. In the crossover study, 31 healthy volunteers completed two randomly ordered test days, a saline day and a ketamine day. Event- related potentials during the talk/ listen task were obtained before infusion and during infusion on both days, and N1 amplitudes were compared across days. In the case- control study, N1 amplitudes from 34 schizophrenia patients and 33 healthy control volunteers were compared. RESULTS: N1 suppression to self produced vocalizations was significantly and similarly diminished by ketamine (Cohen's d= 1.14) and schizophrenia(Cohen's d=.85). CONCLUSIONS: Disruption of NMDARs causes dysfunction in predictive coding during vocalization in a manner similar to the dysfunction observed in schizophrenia patients, consistent with the theorized contribution of NMDAR hypofunction to predictive coding deficits in schizophrenia.
引用
收藏
页码:514 / 524
页数:11
相关论文
共 50 条
  • [31] TRICYCLIC ANTIDEPRESSANTS BLOCK N-METHYL-D-ASPARTATE RECEPTORS - SIMILARITIES TO THE ACTION OF ZINC
    REYNOLDS, IJ
    MILLER, RJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (01) : 95 - 102
  • [32] Mechanism of action of galantamine on N-methyl-D-aspartate receptors in rat cortical neurons
    Moriguchi, S
    Marszalec, W
    Zhao, XL
    Yeh, JZ
    Narahashi, T
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (03): : 933 - 942
  • [33] GLYCINE ACTION ON N-METHYL-D-ASPARTATE RECEPTORS IN RAT HIPPOCAMPAL-NEURONS
    CHIZHMAKOV, IV
    KISKIN, NI
    KRISHTAL, OA
    TSYNDRENKO, AY
    NEUROSCIENCE LETTERS, 1989, 99 (1-2) : 131 - 136
  • [34] Endogenous antagonists of N-methyl-d-aspartate receptor in schizophrenia
    Jorratt, Pascal
    Hoschl, Cyril
    Ovsepian, Saak, V
    ALZHEIMERS & DEMENTIA, 2021, 17 (05) : 888 - 905
  • [35] Schizophrenia:: decreased phosphorylation of N-methyl-D-aspartate receptor?
    不详
    NEUROSCIENTIST, 2004, 10 (04): : 278 - 278
  • [36] Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia
    Tarabeux, J.
    Kebir, O.
    Gauthier, J.
    Hamdan, F. F.
    Xiong, L.
    Piton, A.
    Spiegelman, D.
    Henrion, E.
    Millet, B.
    Fathalli, F.
    Joober, R.
    Rapoport, J. L.
    DeLisi, L. E.
    Fombonne, E.
    Mottron, L.
    Forget-Dubois, N.
    Boivin, M.
    Michaud, J. L.
    Drapeau, P.
    Lafreniere, R. G.
    Rouleau, G. A.
    Krebs, M-O
    TRANSLATIONAL PSYCHIATRY, 2011, 1 : e55 - e55
  • [37] Increased density of glutamate/N-methyl-D-aspartate receptors in superior temporal cortex in schizophrenia
    Nudmamud, S
    Reynolds, GP
    NEUROSCIENCE LETTERS, 2001, 304 (1-2) : 9 - 12
  • [38] Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia
    J Tarabeux
    O Kebir
    J Gauthier
    F F Hamdan
    L Xiong
    A Piton
    D Spiegelman
    É Henrion
    B Millet
    F Fathalli
    R Joober
    J L Rapoport
    L E DeLisi
    É Fombonne
    L Mottron
    N Forget-Dubois
    M Boivin
    J L Michaud
    P Drapeau
    R G Lafrenière
    G A Rouleau
    M-O Krebs
    Translational Psychiatry, 2011, 1 : e55 - e55
  • [39] N-methyl-D-aspartate Receptor Antibody and White Matter Deficits in Schizophrenia Treatment-Resistance
    Tong, Jinghui
    Zhou, Yanfang
    Huang, Junchao
    Zhang, Ping
    Fan, Fengmei
    Chen, Song
    Tian, Baopeng
    Cui, Yimin
    Tian, Li
    Tan, Shuping
    Wang, Zhiren
    Feng, Wei
    Yang, Fude
    Hare, Stephanie
    Goldwaser, Eric L.
    Bruce, Heather A.
    Kvarta, Mark
    Chen, Shuo
    Kochunov, Peter
    Tan, Yunlong
    Hong, L. Elliot
    SCHIZOPHRENIA BULLETIN, 2021, 47 (05) : 1463 - 1472
  • [40] Rare mutations in N-methyl-D-aspartate glutamate receptors in schizophrenia and autism spectrum disorders
    Krebs, M. O.
    Kebir, O.
    Rouleau, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S146 - S146